ID   PLIN1_RAT               Reviewed;         517 AA.
AC   P43884;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 1.
DT   24-JAN-2024, entry version 144.
DE   RecName: Full=Perilipin-1;
DE   AltName: Full=Lipid droplet-associated protein;
GN   Name=Plin1; Synonyms=Peri, Plin;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A AND B), AND PARTIAL PROTEIN
RP   SEQUENCE.
RC   STRAIN=Sprague-Dawley; TISSUE=Adipocyte;
RX   PubMed=7505452; DOI=10.1073/pnas.90.24.12035;
RA   Greenberg A.S., Egan J.J., Wek S.A., Moos M.C. Jr., Londos C., Kimmel A.R.;
RT   "Isolation of cDNAs for perilipins A and B: sequence and expression of
RT   lipid droplet-associated proteins of adipocytes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:12035-12039(1993).
RN   [2]
RP   PHOSPHORYLATION.
RX   PubMed=9755872; DOI=10.1016/s0014-5793(98)01052-7;
RA   Clifford G.M., McCormick D.K., Londos C., Vernon R.G., Yeaman S.J.;
RT   "Dephosphorylation of perilipin by protein phosphatases present in rat
RT   adipocytes.";
RL   FEBS Lett. 435:125-129(1998).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-130; SER-174; THR-299;
RP   THR-301; SER-315; SER-385; SER-387; SER-411; SER-436; SER-440 AND SER-460,
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-408 (ISOFORM B), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Modulator of adipocyte lipid metabolism. Coats lipid storage
CC       droplets to protect them from breakdown by hormone-sensitive lipase
CC       (HSL). Its absence may result in leanness. Plays a role in unilocular
CC       lipid droplet formation by activating CIDEC. Their interaction promotes
CC       lipid droplet enlargement and directional net neutral lipid transfer.
CC       May modulate lipolysis and triglyceride levels (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with ABHD5 (By similarity). Interacts with CIDEC.
CC       Interacts with AQP7 (By similarity). {ECO:0000250|UniProtKB:O60240,
CC       ECO:0000250|UniProtKB:Q8CGN5}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum
CC       {ECO:0000250|UniProtKB:O60240}. Lipid droplet
CC       {ECO:0000250|UniProtKB:O60240}. Note=Lipid droplet surface-associated.
CC       {ECO:0000250|UniProtKB:O60240}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=A; Synonyms=PERIA;
CC         IsoId=P43884-1; Sequence=Displayed;
CC       Name=B; Synonyms=PERIB;
CC         IsoId=P43884-2; Sequence=VSP_004662, VSP_004663;
CC   -!- TISSUE SPECIFICITY: Adipocytes.
CC   -!- PTM: Major cAMP-dependent protein kinase substrate in adipocytes, also
CC       dephosphorylated by PP1. When phosphorylated, may be maximally
CC       sensitive to HSL. When unphosphorylated, may play a role in the
CC       inhibition of lipolysis, by acting as a barrier in lipid droplet.
CC       {ECO:0000269|PubMed:9755872}.
CC   -!- PTM: The N-terminus is blocked.
CC   -!- SIMILARITY: Belongs to the perilipin family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=Fat, wonderful fat - Issue
CC       10 of May 2001;
CC       URL="https://web.expasy.org/spotlight/back_issues/010";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L26043; AAA41830.1; -; mRNA.
DR   EMBL; L26044; AAA41831.1; -; mRNA.
DR   PIR; A49413; A49413.
DR   AlphaFoldDB; P43884; -.
DR   STRING; 10116.ENSRNOP00000068793; -.
DR   GlyGen; P43884; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P43884; -.
DR   PhosphoSitePlus; P43884; -.
DR   PaxDb; 10116-ENSRNOP00000061809; -.
DR   UCSC; RGD:3351; rat. [P43884-1]
DR   AGR; RGD:3351; -.
DR   RGD; 3351; Plin1.
DR   eggNOG; ENOG502RY3Q; Eukaryota.
DR   InParanoid; P43884; -.
DR   PRO; PR:P43884; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:UniProtKB-SubCell.
DR   GO; GO:0005811; C:lipid droplet; IDA:RGD.
DR   GO; GO:0070417; P:cellular response to cold; ISO:RGD.
DR   GO; GO:0016042; P:lipid catabolic process; ISO:RGD.
DR   InterPro; IPR004279; Perilipin.
DR   InterPro; IPR042998; PLIN1.
DR   PANTHER; PTHR47138; PERILIPIN-1; 1.
DR   PANTHER; PTHR47138:SF1; PERILIPIN-1; 1.
DR   Pfam; PF03036; Perilipin; 1.
DR   PIRSF; PIRSF036881; PAT; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Direct protein sequencing; Endoplasmic reticulum;
KW   Lipid droplet; Lipid metabolism; Phosphoprotein; Reference proteome.
FT   CHAIN           1..517
FT                   /note="Perilipin-1"
FT                   /id="PRO_0000099886"
FT   REGION          197..217
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          285..321
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          291..322
FT                   /note="Required for interaction with CIDEC"
FT                   /evidence="ECO:0000250"
FT   REGION          415..495
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        298..319
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         81
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O60240"
FT   MOD_RES         85
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CGN5"
FT   MOD_RES         126
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CGN5"
FT   MOD_RES         130
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         132
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CGN5"
FT   MOD_RES         137
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CGN5"
FT   MOD_RES         174
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         224
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CGN5"
FT   MOD_RES         299
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         301
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         315
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         385
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         387
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         411
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         434
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O60240"
FT   MOD_RES         436
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         440
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         460
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         492
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O60240"
FT   MOD_RES         494
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CGN5"
FT   VAR_SEQ         407..422
FT                   /note="LPRLSLMEPESEFQDI -> VSPAPGPPSDSQGRFD (in isoform B)"
FT                   /evidence="ECO:0000303|PubMed:7505452"
FT                   /id="VSP_004662"
FT   VAR_SEQ         423..517
FT                   /note="Missing (in isoform B)"
FT                   /evidence="ECO:0000303|PubMed:7505452"
FT                   /id="VSP_004663"
FT   MOD_RES         P43884-2:408
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
SQ   SEQUENCE   517 AA;  55614 MW;  1041F76DC2F55A25 CRC64;
     MSMNKGPTLL DGDLPEQENV LQRVLQLPVV SGTCECFQKT YNSTKEAHPL VASVCNAYEK
     GVQGASNLAA WSMEPVVRRL STQFTAANEL ACRGLDHLEE KIPALQYPPE KIASELKGTI
     STRLRSARNS ISVPIASTSD KVLGATLAGC ELALGMAKET AEYAANTRVG RLASGGADLA
     LGSIEKVVEY LLPPDKVESA PSSGRQKTQK APKAKPSLLR RVSTLANTLS RHTMQTTARA
     LKRGHSLAMW IPGVAPLSSL AQWGASAAMQ VVSRRQSEVR VPWLHNLAAS KDENHEDQTD
     TEGEETDEEE EEEESEAEEN VLREVTALPT PLGFLGGVVH TVQKTLQNTI SAVTWAPAAV
     LGTVGRILHL TPAQAVSSTK GRAMSLSDAL KGVTDNVVDT VVHYVPLPRL SLMEPESEFQ
     DIDNPPAEVE RKGSGSRPAS PESTARPGQP RAACAVRGLS APSCPDLDDK TETSARPGLL
     AMPREKPARR VSDSFFRPSV MEPILGRTQY SQLRKKS
//
